HEMOSIL LIQUID ANTITHROMBIN XL— 510(k) K033775

Name: FDA 510(k) clearance K033775
Creator: U.S. Food and Drug Administration
Published: 2004-01-02

Substantially Equivalent

Instrumentation Laboratory CO

FDA 510(k) clearance K033775 for HEMOSIL LIQUID ANTITHROMBIN XL, Substantially Equivalent on 2004-01-02. Applicant: Instrumentation Laboratory CO. Device class: 2.

Clearance details

Applicant: Instrumentation Laboratory CO
Product code: Code JBQ
Device class: Class 2
Regulation: 21 CFR 864.7060
Advisory panel: Hematology
Date received: 2003-12-03
Decision date: 2004-01-02
Decision: Substantially Equivalent
Clearance type: Special
Location: Bedford, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JBQ

view all

K242952 — INNOVANCE Antithrombin2025-03-28
K081769 — INNOVANCE ANTITHROMBIN WITH MODELS OPFH03, OPFHO52009-05-28
K070301 — HEMOSIL ANTITHROMBIN2007-02-23
K062431 — HEMOSIL LIQUID ANTITHROMBIN2006-09-01
K043007 — BIOPHEN ANTITHROMBIN 2.5, REFERENCE # 221102; BIOPHEN ANTITHROMBIN 5, REFERENCE # 2211052005-11-07

More clearances from Instrumentation Laboratory CO

view all

K221359 — ACL TOP 970 CL, HemosIL CL Anti-Cardiolipin IgM, HemosIL CL Anti-ß2 Glycoprotein-I IgM2023-09-29
K223187 — HemosIL Liquid Anti-Xa2023-06-23
K223090 — GEM Premier ChemSTAT2023-01-27
K223402 — HemosIL von Willebrand Factor Antigen2022-12-09
K213464 — HemosIL Liquid Anti-Xa2022-10-04

Data sourced from openFDA. This site is unofficial and independent of the FDA.